317 - Characterization of MK-4166, a clinical agonistic mAb that targets human GITR and inhibits the generation and activity of Tregs
| Autor: | Sukumar, S., Wison, D., Yu, Y., Wong, J., Naravula, S., Ermakov, G., Bhagwat, B., Grein, J., Churakova, T., Mangadu, R., Sriram, V., Bailey, W., Herzyk, D., Mcclanahan, T., Willingham, A., Beebe, A., Sadekova, S. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S104-S104 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect